Enquiries? Call Oxford Biosystems Now on 01235 431390 or email sales@oxfordbiosystems.com

Oxford Biosystems News

From the category archives: Infectious Diseases

Infectious Diseases

Urinary Antigen Testing

Pneumonia is a common illness affecting approximately 450 million people a year and occurring in all parts of the world. It is a major cause of death among all age groups, resulting in 4 million deaths annually – 7% of total world annual deaths.1

Read the rest of entry »


Oxford Biosystems has pledged to be an Antibiotic Guardian

Oxford Biosystems has pledged to be an Antibiotic Guardian

Antibiotic resistance is one of the biggest threats facing us today.

Without effective antibiotics many routine treatments will become increasingly dangerous. Setting broken bones, basic operations, even chemotherapy and animal health all rely on access to antibiotics that work.

Read the rest of entry »


New rapid test supports NHS objectives for early diagnosis of Sepsis


NHS England has urged healthcare professionals to “focus on improving early recognition and timely treatment of sepsis.” Based on DNA Flow technology, the Sepsis Flow Chip can detect a wide range of pathogens and antibiotic resistant genes from patient blood cultures.

Read the rest of entry »


Unique, patented, rapid test combats Antibiotic resistance


A revolutionary new rapid test to support clinicians in countering the threat of Antimicrobial Resistance (AMR) has been developed by the international biotechnology company Master Diagnostica and is being exclusively supplied in the UK through Oxford Biosystems.

Read the rest of entry »


Oxford Biosystems Limited – members of BIVDA

www.bivda.co.ukThe British In Vitro Diagnostics Association represents the IVD Industry in the UK, to Government, professional bodies, the public, and at the European Diagnostic Manufacturers Association. BIVDA promotes the clinical and cost utility of IVDs in the provision of effective healthcare, both in acute diagnosis and in the prediction and prevention of disease.

Read the rest of entry »


NEW Distribution agreement confirmed with Labsystems Diagnostics Oy

Labsystems Diagnostic

Labsystems Diagnostics has been a pioneer in diagnostic development for 30 years. The company develops, manufactures and markets high quality enzyme immunoassays (EIA and FEIA) and rapid Point of Care (POC) tests globally for clinical laboratory use, home use and doctors offices.

As a result of the new distribution agreement, Oxford Biosystems will represent Labsystems Diagnostics in the UK and the Republic of Ireland. The Labsystems products for infectious diseases and gastrointestinal disorders will complement the existing Oxford Biosystems product range extremely well. As a pioneer in Newborn Screening (NBS) Labsystems have a range of high quality products and instrumentation that we are looking forward to introducing to our customers.

    www.labsystemsdx.com


Manage Human MxA Protein

Human MxA protein (Myxovirus resistance protein 1), the product of the MX1 gene, is a 76-kDa protein consisting of 662 amino acid residues and belonging to the dynamic superfamily of large GTPase. MxA protein plays an important role in antiviral activity in cells against a wide variety of viruses. These include:

Read the rest of entry »


Oxford Biosystems

115J Olympic Avenue

Milton Park

Oxfordshire

OX14 4SA

Oxford Biosystems has pledged to be an Antibiotic Guardian

Members of:

BIVDA Member 2017